my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
20-07-2010: The Tecan Group and NEXUS Biosystems, Inc., based in Poway, have signed an agreement concerning the sale of REMP AG, a wholly-owned subsidiary of Tecan, as well as other related assets. Under this agreement, NEXUS will acquire all activities of Tecan's Sample Management business segment. In parallel with this move, Tecan and NEXUS plan to collaborate on various additional product groups. With this transaction Tecan increases the focus on its Life Sciences core business, which it will expand further in line with its growth strategy.
REMP AG, located in Oberdiessbach (Switzerland), employed a total of 120 employees worldwide at the end of 2009. Segment sales from the activities performed by Tecan's Sample Management business segment reached CHF 35.7 million in 2009, with a small positive operating profit of CHF 0.1 million. The selling price for REMP AG and the related activities amounts to a total of CHF 12 million. Up until the end of 2012, Tecan will also receive additional payments from NEXUS Biosystems based on sales generated together with REMP AG of between a minimum of USD 4.4 million and a maximum of USD 7.7 million. The transaction should be closed within the next two months. With the closing of the transaction, the Head of Business Unit Sample Management, Domingo Messerli, will resign from the Executive Board of the Tecan Group in this function.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
Tecan Award 2011 winner announced
Tecan announced the results of the Tecan Award 2011. The award has been won by Svenja Kristina Holle from the University Hospital of Muenster (UHM), Germany. Using an Infinite® 200 microplate reader, Svenja and the UHM team have developed an ex vivo method for investigating the dynamics of ... more
Tecan and Attana extend distribution agreement
Tecan and Attana AB have announced an extended distribution agreement under which Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology in Europe. This collaboration covers the Attana 100, Attana 200 and Cell 200 instruments, ... more
Tecan concludes the sale of the Sample Management activities to NEXUS Biosystems
The Tecan Group announced that the sale of REMP AG, a wholly owned subsidiary of Tecan, as well as other related assets, to NEXUS Biosystems has been completed as planned. From September 1, 2010, the Sample Management business segment will no longer be consolidated within the Tecan Group. ... more
Tecan is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. With its subsi ... more
Tecan concludes the sale of the Sample Management activities to NEXUS Biosystems
The Tecan Group announced that the sale of REMP AG, a wholly owned subsidiary of Tecan, as well as other related assets, to NEXUS Biosystems has been completed as planned. From September 1, 2010, the Sample Management business segment will no longer be consolidated within the Tecan Group. ... more
Tecan sells sample management business to US firm NEXUS Biosystems
The Tecan Group and NEXUS Biosystems, Inc., based in Poway, have signed an agreement concerning the sale of REMP AG, a wholly-owned subsidiary of Tecan, as well as other related assets. Under this agreement, NEXUS will acquire all activities of Tecan's Sample Management business segment. In ... more
REMP is the global leader in the supply of large-scale automated storage and retrieval systems for sample management in the pharmaceutical and biotechnology industries. Sample management is a key foundation of the drug discovery and development process as compound libraries represent one of ... more
Tecan concludes the sale of the Sample Management activities to NEXUS Biosystems
The Tecan Group announced that the sale of REMP AG, a wholly owned subsidiary of Tecan, as well as other related assets, to NEXUS Biosystems has been completed as planned. From September 1, 2010, the Sample Management business segment will no longer be consolidated within the Tecan Group. ... more
Tecan sells sample management business to US firm NEXUS Biosystems
The Tecan Group and NEXUS Biosystems, Inc., based in Poway, have signed an agreement concerning the sale of REMP AG, a wholly-owned subsidiary of Tecan, as well as other related assets. Under this agreement, NEXUS will acquire all activities of Tecan's Sample Management business segment. In ... more
Nexus Biosystems forms European Subsidary
NEXUS Biosystems, Inc. announced the opening of a wholly owned European subsidiary, NEXUS Biosystems GmbH, located in Munich, Germany. "The demand for NEXUS products in Europe has been steadily growing," said John Lillig, President and CEO of NEXUS Biosystems. "With the successful sales ov ... more
NEXUS Biosystems is a privately-held life science company focused on the development of enabling technologies and automation systems for pharmaceutical, biotech and academic research institutions worldwide. NEXUS products include the growing family of Universal Store™ sample management syst ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
